title: Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA).
authors.affiliation: Department of Medicine, Ruhr-University, Knappschafts-Krankenhaus, Bochum, Germany.
authors.forename: Juris J
authors.initials: JJ
authors.lastname: Meier
authors.forename: Silvia
authors.initials: S
authors.lastname: Deifuss
authors.forename: Andreas
authors.initials: A
authors.lastname: Klamann
authors.forename: Volker
authors.initials: V
authors.lastname: Launhardt
authors.forename: Wolff H
authors.initials: WH
authors.lastname: Schmiegel
authors.forename: Michael A
authors.initials: MA
authors.lastname: Nauck
mesh_terms: D001786:Blood Glucose; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000401:mortality*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008297:Male; D015999:Multivariate Analysis; D009203:Myocardial Infarction / Q000401:mortality*; D016016:Proportional Hazards Models; D016019:Survival Analysis
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin